B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Cd56 Antigen

81 PubMed studies analyzed · 2 RCTs · Evidence Score: 45.4

Research Domains

Cd56 Antigen has been studied across 14 research domains including 🔬 Oncology, 🛡️ Immunity, 🧬 Hormones, 🔬 Inflammation, 😴 Sleep. The primary research focus is 🔬 Oncology with 65% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cd56 Antigen is generated deterministically from 81 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.